Gabelli Ebit from 2010 to 2025

GRX Stock  USD 9.95  0.06  0.61%   
Gabelli Healthcare EBIT yearly trend continues to be fairly stable with very little volatility. EBIT will likely drop to about 2.6 M in 2025. During the period from 2010 to 2025, Gabelli Healthcare EBIT regression line of annual values had r-squared of  0.14 and arithmetic mean of  18,994,835. View All Fundamentals
 
EBIT  
First Reported
2010-12-31
Previous Quarter
2.7 M
Current Value
2.6 M
Quarterly Volatility
23.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Gabelli Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gabelli Healthcare's main balance sheet or income statement drivers, such as Interest Expense of 3.4 M, Selling General Administrative of 734 K or Total Revenue of 1.1 M, as well as many indicators such as Price To Sales Ratio of 113, Dividend Yield of 0.0562 or PTB Ratio of 0.61. Gabelli financial statements analysis is a perfect complement when working with Gabelli Healthcare Valuation or Volatility modules.
  
Check out the analysis of Gabelli Healthcare Correlation against competitors.

Latest Gabelli Healthcare's Ebit Growth Pattern

Below is the plot of the Ebit of Gabelli Healthcare WellnessRx over the last few years. It is Gabelli Healthcare's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gabelli Healthcare's overall financial position and show how it may be relating to other accounts over time.
Ebit10 Years Trend
Slightly volatile
   Ebit   
       Timeline  

Gabelli Ebit Regression Statistics

Arithmetic Mean18,994,835
Geometric Mean13,091,578
Coefficient Of Variation125.19
Mean Deviation18,994,162
Median31,689,144
Standard Deviation23,778,944
Sample Variance565.4T
Range97.4M
R-Value(0.37)
Mean Square Error521.3T
R-Squared0.14
Significance0.15
Slope(1,866,061)
Total Sum of Squares8481.6T

Gabelli Ebit History

20252.6 M
20242.7 M
2023M
2022-44.3 M
202142.7 M
202024.2 M
201953.2 M

Other Fundumenentals of Gabelli Healthcare

About Gabelli Healthcare Financial Statements

Gabelli Healthcare investors use historical fundamental indicators, such as Gabelli Healthcare's Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Gabelli Healthcare. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBIT2.7 M2.6 M
EBITDA2.9 M2.7 M
Ebt Per Ebit 0.15  0.14 
Ebit Per Revenue 2.33  2.44 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Gabelli Stock Analysis

When running Gabelli Healthcare's price analysis, check to measure Gabelli Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gabelli Healthcare is operating at the current time. Most of Gabelli Healthcare's value examination focuses on studying past and present price action to predict the probability of Gabelli Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gabelli Healthcare's price. Additionally, you may evaluate how the addition of Gabelli Healthcare to your portfolios can decrease your overall portfolio volatility.